TCL Archive Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief. December 19, 2008
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment May 23, 2014
